Back to newsroom
News
Drug That Gives Pancreatic Cancer Patients More Time is Out of Reach

September 24, 2020

Drug That Could Give Pancreatic Cancer Patients More Time is Out of Reach: Healthing.com

PCC CEO Michelle Capobianco, pancreatic cancer researchers and patient advocates question the pan-Canadian Pharmaceutical Alliance (pCPA) delaying the funding of pancreatic cancer treatment ONIVYDE, which was approved by Health Canada three years ago.Healthing FILE PHOTO: Justice Ruth Bader Ginsburg attends the lunch session of The Women's Conference in Long Beach, California October 26, 2010. REUTERS/Mario Anzuoni/File Photo ORG XMIT: FW1

Be part of the force driving answers for this devastating disease.

Make a donation towards pancreatic cancer research and support programs.

donate today

Keep in the loop:

Read more PCNA News:

discover more

July 9, 2026

Research
National Coverage Highlights the Urgent Need for Progress in Pancreatic Cancer

May 13, 2026

Research
Pancreatic Cancer North America launches access to free genomic testing with OncoHelix to support treatment decisions for patients across Canada

June 13, 2025

Research
Research Update – NeoPancONE Study Results Presented at ASCO 2025